Endoplasmic Reticulum Localized Bcl-2 Prevents Apoptosis when Redistribution of Cytochrome C is a Late Event
Overview
Affiliations
The disruption of mitochondrial function is a key component of apoptosis in most cell types. Localization of Bcl-2 to the outer mitochondrial and endoplasmic reticulum membranes is consistent with a role in the inhibition of many forms of apoptosis. In Rat-1 cells, a Bcl-2 mutant targeted exclusively to the endoplasmic reticulum (Bcl-cb5) was effective at inhibiting apoptosis induced by serum starvation/myc, or ceramide but not apoptosis induced by etoposide. The former conditions cause a decrease in mitochondrial transmembrane potential (Deltapsi(m)) as an early event that precedes the release of cytochrome c from mitochondria. By contrast, when cells are exposed to etoposide, a situation in which cytochrome c release and membrane localization of the pro-apoptotic protein Bax precede loss of Deltapsi(m), wild type Bcl-2 but not Bcl-cb5 prevents apoptosis. Therefore, Bcl-2 functions in spatially distinct pathways of apoptosis distinguished by the order of cytochrome c release and loss of Deltapsi(m).
Bcl-2 and Bcl-xL in Diabetes: Contributions to Endocrine Pancreas Viability and Function.
Perez-Serna A, Guzman-Llorens D, Dos Santos R, Marroqui L Biomedicines. 2025; 13(1).
PMID: 39857806 PMC: 11760435. DOI: 10.3390/biomedicines13010223.
Read T, Cisterna B, Skruber K, Ahmadieh S, Liu T, Vitriol J EMBO Rep. 2024; 25(8):3240-3262.
PMID: 39026010 PMC: 11316047. DOI: 10.1038/s44319-024-00209-3.
The C-terminal sequences of Bcl-2 family proteins mediate interactions that regulate cell death.
Nguyen D, Osterlund E, Kale J, Andrews D Biochem J. 2024; 481(14):903-922.
PMID: 38985308 PMC: 11346437. DOI: 10.1042/BCJ20210352.
MTCH2 cooperates with MFN2 and lysophosphatidic acid synthesis to sustain mitochondrial fusion.
Goldman A, Mullokandov M, Zaltsman Y, Regev L, Levin-Zaidman S, Gross A EMBO Rep. 2024; 25(1):45-67.
PMID: 38177900 PMC: 10897490. DOI: 10.1038/s44319-023-00009-1.
Hypericin, a potential new BH3 mimetic.
Doroshenko A, Tomkova S, Kozar T, Stroffekova K Front Pharmacol. 2022; 13:991554.
PMID: 36267274 PMC: 9577225. DOI: 10.3389/fphar.2022.991554.